Otoprotective properties of mannitol against gentamicin induced hair cell loss

Otology and Neurotology

Volumn 35, Issue 5, 2014, Pages

  Wood, John William ^a   Bas, Esperanza ^a   Gupta, Chhavi ^a   Selman, Yamil ^b   Eshraghi, Adrien ^a   Telischi, Fred F ^a   Van De Water, Thomas R ^a  

^a UNIVERSITY OF MIAMI EAR INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Aminoglycoside; Hair cell loss; Mannitol; Otoprotection; Ototoxicity; Reactive oxygen species

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOOXYGENASE 2; GENTAMICIN; INTERLEUKIN 1BETA; MANNITOL; PTGS2 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TNFRSF1A PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; CORTI ORGAN; DRUG EFFECTS; HAIR CELL; METABOLISM; PATHOLOGY; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; CYCLOOXYGENASE 2; GENTAMICINS; HAIR CELLS, AUDITORY; INTERLEUKIN-1BETA; MANNITOL; ORGAN OF CORTI; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901598406     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000342     Document Type: Article

References (28)

1. Bertolaso L, Bindini D, Previati M, et al. Gentamicin-induced cytotoxicity involves protein kinase C activation, glutathione extrusion and malondialdehyde production in an immortalized cell line from the organ of Corti. Audiol Neurootol 2003;8:38-48. (Pubitemid 36098751)
2. NordangL, Anniko M. Nitro-L-argininemethylester: a potential protector against gentamicin ototoxicity. Acta Otolaryngol 2005;125:1033-8. (Pubitemid 41510692)
3. Xie J, Talaska AE, Schacht J. New developments in aminoglycoside therapy and ototoxicity. Hear Res 2011;281:28-37.
4. Bailey RR, Begg EJ, Smith AH, et al. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol 1996;46:183-6. (Pubitemid 26306528)
5. Alharazneh A, Luk L, Huth M, et al. Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity. PLoS ONE 2011;6:e22347.
6. Cunningham L, Tan J. Cell death in the inner ear. In: Reed JC, Green DR, eds. Apoptosis: Physiology and Pathology. Cambridge, UK: Cambridge University Press, 2011;182-93.
7. McDowell B. Patterns of cochlear degeneration following gentamicin administration in both old and young guinea pigs. Brit J Audiol 1982;16:123-9. (Pubitemid 12122767)
8. Ylikoski J, Xing-Qun L, Virkkala J, Pirvola U. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res 2002;163:71-81. (Pubitemid 34098843)
9. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int 2007;72:931-5. (Pubitemid 47530566)
10. Bas E, Van De Water TR, Gupta C, et al. Efficacy of three drugs for protecting against gentamicin-induced hair cell and hearing losses. Brit J Pharmacol 2012;166:1888-904.
11. Chen F, Schacht J, Sha S. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. J Neurochem2009; 108:1226-36.
12. Suzuki J, Imaizumi S, Kayama T, et al. Chemiluminescence in hypoxic brain -the second report: cerebral protective effect of mannitol, vitamin E and glucocorticoid. Stroke 1985;16:695-700. (Pubitemid 15007248)
13. Kobayashi H, Ide H, Kabuto M, et al. Effect of mannitol on focal cerebral ischemia evaluated by somatosensory-evoked potentials and magnetic resonance imaging. Surg Neurol 1995;44:55-62.
14. Schrier RW, Arnold PE, Gordon JA, et al. Protection of mitochondrial function by mannitol in ischemic acute renal failure. Amer J Physiol 1984;247:365-9.
15. Ouriel K, Ginsburg ME, Patti CS, et al. Preservation of myocardial function with mannitolreperfusate. Circulation 1985;72(Suppl.):254-8.
16. Magovern GJ Jr, Bolling SF, Casale AS, et al. The mechanism of mannitol in reducing ischemic injury: hyperosmolarity or hydroxyl scavenger? Circulation 1984;70(Suppl):91-5.
17. Quirk WS, Dengerink HA, Bademian MJ, et al. Mannitol and dextran increase cochlear blood flow in normotensive and spontaneously hypertensive rats. Acta Otolaryngol 1990;109:383-8. (Pubitemid 20192335)
18. Yoshida M, Uemura T. Effect of glycerol and mannitol on perilymphatic PO2 in guinea pig cochlea. Otolaryngol HNS 1991;104:495-8.
19. Tabuchi K, Ito Z, Wada T, et al. The effect of mannitol upon cochlear dysfunction induced bytransient local anoxia. Hear Res 1998;126:28-36. (Pubitemid 29003089)
20. Infante-Bas E, Channer GA, Telischi FF, et al. Labyrinthine barriers and cochlear homeostasis. Otol Neurotol 2012;33:1656-63.
21. Juhn SK, Rybak LP. Mannitol protects auditory hair cells against tumour necrosis factor alpha (TNF->)-induced loss. Acta Otolaryngol 1981;91:529-34.
22. Chelikh L, Teixeira M, Martin C. High variability of perilymphatic entry of neutral molecules through the round window. Acta Otolaryngol 2003;123:199-202. (Pubitemid 36359791)
23. Hahn H, Kammerer B, DiMauro A, et al. Cochlear microdialysis for quantification of dexamethasone and flourescein entry into scala tympani during round window administration. Hear Res 2006;212:236-44. (Pubitemid 43254952)
24. Morawski K, Telischi FF, Merchant F, et al. Role of mannitol in reducing postischemic changes in distortion-product otoacoustic emissions (DPOAEs): a rabbit model. Laryngoscope 2003;113:1615-22. (Pubitemid 37087849)
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-$$ctmethod. Methods 2001;25:402-8. (Pubitemid 34164012)
26. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 1969;11:1-21.
27. Choung YH, Taura A, Pak K, Choi SJ, Masuda M, Ryan AF. (2009). Generation of highly-reactive oxygen species (hROS) is closely related to hair cell damage in rat organ of Corti treated with gentamicin. Neurosci 2009;161:214-26.
28. Sha S-H, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001;155:1-8. (Pubitemid 32401586)